Related Experiment Video
Updated: Jun 22, 2026
07:30
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
The endocannabinoid system as a target for modelling psychosis
Dagmar Koethe1, Carolin Hoyer, F Markus Leweke
1Central Institute of Mental Health, Ruprecht-Karls-University Heidelberg, Mannheim, Germany.
Psychopharmacology
|June 17, 2009
Summary
Model psychosis research helps understand schizophrenia by examining altered states of consciousness. This review focuses on endocannabinoid system studies relevant to psychosis, offering insights into schizophrenia
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Model psychosis involves experimentally induced symptoms mimicking schizophrenia.
- Altered states of consciousness are key to understanding psychosis.
- The endocannabinoid system's role in schizophrenia is increasingly recognized, particularly concerning cannabis use.
Purpose of the Study:
- To review studies on model psychosis and its relation to the endocannabinoid system.
- To assess the contribution of model psychosis experiments to understanding psychosis neurobiology.
- To outline future research directions and link to other psychosis models.
Main Methods:
- Literature review of studies on model psychosis.
- Analysis of data linking endocannabinoid system to psychosis.
- Synthesis of findings to inform future research.
Main Results:
- Model psychosis studies offer valuable insights into schizophrenia.
- The endocannabinoid system is a relevant target for psychosis research.
- Existing research primarily focuses on cannabis and cannabinoids, not always directly related to psychosis.
Conclusions:
- Model psychosis research is crucial for advancing our understanding of schizophrenia.
- Further investigation into the endocannabinoid system's role in psychosis is warranted.
- Future studies should integrate model psychosis findings with broader neurobiological approaches.
Related Concept Videos
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...